Lexicon Pharmaceuticals
LXRX
#6680
Rank
โ‚น76.10 B
Marketcap
โ‚น170.93
Share price
2.25%
Change (1 day)
35.81%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): -โ‚น55.84

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น14.09. In 2022 the company made an earnings per share (EPS) of -โ‚น57.29 an increase over its 2021 EPS that were of -โ‚น57.29.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น55.84-2.53%
2022-โ‚น57.29-0%
2021-โ‚น57.2910.91%
2020-โ‚น51.65-145.08%
2019โ‚น114.58-206.09%
2018-โ‚น108.01-5.74%
2017-โ‚น114.58-10.95%
2016-โ‚น128.672640%
2015-โ‚น4.70-96.34%
2014-โ‚น128.16-2.53%
2013-โ‚น131.49-9.09%
2012-โ‚น144.63-37.14%
2011-โ‚น230.100%
2010-โ‚น230.10-39.66%
2009-โ‚น381.313.57%
2008-โ‚น368.16-8.2%
2007-โ‚น401.03-24.69%
2006-โ‚น532.5242.11%
2005-โ‚น374.73-22.97%
2004-โ‚น486.50-35.09%
2003-โ‚น749.47-0%
2002-โ‚น749.4762.86%
2001-โ‚น460.20-19.54%
2000-โ‚น571.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,784-12,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น553.18-4,026.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,936-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น548.48 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น940.12-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.88-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น70.44 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น35.69-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น2,751 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA